Tag: Europe
-
Human Antibodies Devised for Snakebite Treatment
An academic-industry team in Europe and Central America assembled a group of human antibodies that protects lab mice against venomous toxins from a dangerous African snake.
-
Novartis, NGO Partner on Generic Antibiotics
Drug maker Novartis and a not-for-profit organization delivering antibiotics for low- and middle-income countries are collaborating on production of generic antibiotics for children.
-
Synthetic Antibody Neutralizing Gluten in Development
An academic-business team is developing a synthetic antibody to prevent gluten found in some grains from affecting the intestines of people with celiac disease, an intolerance of gluten.
-
Liquid Biopsy for Solid Tumors Now Available
A test that inspects a patient’s blood sample for characteristic indicators of solid-tumor cancer, and can be part of a comprehensive precision analytics program, is now on the market.
-
Spin-Off Company Developing New Antibiotics
A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections.
-
Virtual Reality Therapy Company Gains $5.1M in Early Funds
A company in the U.K. developing automated treatments for phobias using immersive virtual reality is raising £3.2 million ($US 5.1 million) in its first venture funding round.
-
Infographic – Countries with Fastest Internet Speeds
In this weekend’s infographic, we offer a report from the Worldwide Broadband Speed League, a year-long compilation of 163 million Internet speed tests in 200 countries.
-
Univ. Spin-Off Developing A.I.-Boosted Heart Monitor
A new enterprise in the U.K. is developing a wearable heart monitor that diagnoses irregular heart rhythms with artificial intelligence using cloud-based algorithms.
-
Scientists, Investors Form $100M+ Tech Venture Fund
A group of entrepreneurs and leading scientists in the U.K. unveiled a venture investment fund that plans to back start-up companies developing a wide range of ground-breaking technologies.
-
Genentech Gains Modular Engineered Antibodies in $5B Deal
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers.